Detection and Characterization of Pulmonary Disease by Transthoracic Doppler (TTD)
Sponsor: Echosense Ltd.
Terminated
Low recruiting rate and fulfill requirements
Other terminated trials from Echosense Ltd.
- Pulmonary Hypertension · Jul 2021
- ADHF · Phase NA · Jul 2021
- Pulmonary Embolism · Phase NA · Jan 2019
- Pulmonary Hypertension · Feb 2017
- Pulmonary Hypertension · Phase NA · Dec 2015
More terminations from Echosense Ltd.
Listed as NCT01618721, this observational or N/A phase trial focuses on Lung Disease, Chronic Obstructive and Lung Disease, Interstitial and remains terminated or withdrawn. Sponsored by Echosense Ltd., it has been updated 8 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Mar 2022 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Mar 2022 [monthly]
Terminated
-
Sep 2019 — Jan 2021 [monthly]
Terminated
▶ Show 3 earlier versions
-
Jun 2018 — Sep 2019 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Dec 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Echosense Ltd.
- University of Maryland
For direct contact, visit the study record on ClinicalTrials.gov .